Dr Moira Cruickshank
Research Fellow
- About
-
- Email Address
- m.cruickshank@abdn.ac.uk
- Office Address
Health Services Research Unit
3rd Floor Health Sciences Building
Foresterhill
Aberdeen
AB25 2ZD- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Moira Cruickshank is a Research Fellow in the Evidence Synthesis programme of ACE.
Moira was a Police Officer in the Metropolitan Police before returing to full time education at the University of Aberdeen in 2002. She graduated with BSc (Hons) Psychology in 2006 and MRes Psychology in 2007. Moira then undertook a PhD in Psychology within HSRU (now ACE), supervised by Prof Jill Francis, Dr Rachael Powell and Prof James N'Dow. The PhD was funded by UCAN, a local charity aiming to improve the experience and outcomes of people diagnosed with urological cancer. Since completing her PhD in 2011, Moira has been a systematic reviewer within the Evidence Synthesis programme and is involved in technology assessment appraisals and health technology assessment reviews.
- Publications
-
Page 1 of 2 Results 1 to 25 of 46
The regenerate study: A non-randomised feasibility study of an intervention to reduce anticholinergic burden in older patients
Geriatrics, vol. 9, no. 6, 152Contributions to Journals: ArticlesAlternatives to surveillance for persistent human papillomavirus after a positive cervical screen:: A systematic review and meta-analysis
European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 302, pp. 332-338Contributions to Journals: ArticlesAutomated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis
Health Technology Assessment, vol. 28, no. 37, pp. i-xxv, 1-158Contributions to Journals: ArticlesThe effects and safety of testosterone replacement therapy for men with hypogonadism: The TestES evidence synthesis and economic evaluation
Health Technology Assessment, vol. 28, no. 43Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/JRYT3981
- [ONLINE] View publication in Scopus
What is the impact of long-term COVID-19 on workers in healthcare settings? A rapid systematic review of current evidence
PloS ONE, vol. 19, no. 3 , e0299743Contributions to Journals: Review articlesCost-effectiveness of testosterone treatment utilising individual patient data from randomised controlled trials in men with low testosterone levels
Andrology, vol. 12, no. 3, pp. 477-486Contributions to Journals: ArticlesIvosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
National Institute for Health and Care Excellence (NICE). 20 pagesBooks and Reports: Commissioned Reports- [ONLINE] https://www.nice.org.uk/guidance/ta948
- [ONLINE] Page 214-316
- [ONLINE] https://www.nice.org.uk/guidance/ta948/evidence
Clinical Predictors Of Symptomatic Benefit In Men With Low Testosterone During Testosterone Treatment Compared With Placebo:: Results Of Individual Patient And Aggregate Data Meta-analyses
Annual Meeting of the Endocrine Society 2023, bvad114.1704Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1210/jendso/bvad114.1704
Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis
The Lancet Healthy Longevity, vol. 4, no. 10, pp. e561-e572Contributions to Journals: ArticlesDeucravacitinib for treating moderate-to-severe plaque psoriasis
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 155 pagesBooks and Reports: Commissioned ReportsPMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
Annual Meeting of the Endocrine Society 2022Contributions to Conferences: Posters- [ONLINE] DOI: https://doi.org/10.1210/jendso/bvac150.1447
PMON258 Patient-Reported Outcomes for men with Hypogonadism and the Impact of Low Testosterone Levels: a review of measures
Annual Meeting of the Endocrine Society 2022Contributions to Conferences: Posters- [ONLINE] DOI: https://doi.org/10.1210/jendso/bvac150.1445
Management of the first stage of convulsive status epilepticus in adults: a systematic review of current randomised evidence
Journal of Neurology, vol. 269, no. 7, pp. 3420-3429Contributions to Journals: Review articlesAxicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after one systemic therapy
London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 128 pagesBooks and Reports: Commissioned ReportsAdverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
The Lancet Healthy Longevity, vol. 3, no. 6, pp. e381–393Contributions to Journals: ArticlesDoes weight management research for adults with severe obesity represent them? Analysis of systematic review data
BMJ Open, vol. 12, no. 5, e054459Contributions to Journals: ArticlesIdentifying the outcomes important to men with hypogonadism: a qualitative evidence synthesis
Journal of Andrology, vol. 10, no. 4, pp. 625-641Contributions to Journals: ArticlesAxicabtagene ciloleucel for treating relapsed or refractory low-grade non-Hodgkin lymphoma
London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 106 pagesBooks and Reports: Commissioned ReportsPre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis
Health technology assessment (Winchester, England), vol. 26, no. 20, pp. 1-76Contributions to Journals: ArticlesRelugolix with oestradiol and norethisterone acetate for treating uterine fibroids
Commissioned by National Institute for Health and Care Excellence. London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 171 pagesBooks and Reports: Commissioned ReportsBarriers and facilitators to reducing anticholinergic burden: a qualitative systematic review
International Journal of Clinical Pharmacy, vol. 43, pp. 1451-1460Contributions to Journals: ArticlesTeduglutide for treating short bowel syndrome
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 123 pagesBooks and Reports: Commissioned ReportsPalforzia for treating peanut allergy
London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 125 pagesBooks and Reports: Commissioned ReportsIdentification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in depth analysis to inform the development of a core outcome set
BMJ Open, vol. 11, no. 6, e045568Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/bmjopen-2020-045568
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/16884/1/Cruickshank_etal_BMJO_Identification_and_categorisation_VOR.pdf
- [ONLINE] https://abdn.pure.elsevier.com/en/en/researchoutput/identification-and-categorisation-of-relevant-outcomes-for-symptomatic-uncomplicated-gallstone-disease(e370a043-95ee-45d1-8c15-857c465dacda).html
Venetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy
London: National Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned Reports